Share Sounds from Modern Mindset related to Investing in Funds

Adam Cox is joined by Randeep Somel, Fund Manager for Climate Solutions Fund at M&G Investments, for World Earth Day to discuss impact investing, and the size of the opportunity to get to net-zero by 2056. Randeep explains some of the constraints that could arise in getting to net zero, and how impact investing can help the environment. www.mandg.com

Adam Cox is joined by Chand Chudasama, Partner in Strategic Corporate Finance at Price Bailey, to discuss new data which highlights considerable investment growth for regions of the UK. They look at the sort of industries that are currently particularly popular with venture capitalists, and Chand gives advice to business owners currently looking for investment. www.pricebailey.co.uk

Adam Cox is joined by podcaster and property investor, Pete Lonton. They discuss his approach to investing, and what he's learned from interviewing so many people that have fire in their belly. While many people in life value comfort and convenience, a small percent of the population have a relentless desire to grow and achieve. How and why do these people have fire in the belly? Pete offers some tips and advice for anyone to become more motivated and focussed.

Adam Cox talks to international speaker and passive income coach, Douglas Vermeeren. Douglas explains why most of the population rely on only a single source of income – often through conventional employment – and explains that what was taught in schools as being a source of security is actually a very risky strategy. He discusses why having multiple streams of income (some of which are passive) enables us to have more security and freedom simultaneously, and offers a few tips about how to make the transition from employee status into the world of having passive incomes.

Adam talks to Richard Stead, a chemist and scientist that is creating a pioneering approach to deal with the problem of what to do when our antibiotics stop working. The head of the World Health Organisation has said that antibiotic resistance is one of the major threats to the world, and warns of an antibiotic apocalypse. Despite these grave concerns, big Pharma companies are not developing alternatives. Richard discusses why this is the case, and how it is an opportunity for both savvy and ethical investors.